Health Care & Life Sciences » Pharmaceuticals | CCM Duopharma Biotech Bhd

CCM Duopharma Biotech Bhd | Income Statement

Fiscal year is January-December. All values MYR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
162,405.00
176,961.00
269,794.00
312,940.00
467,987.00
Cost of Goods Sold (COGS) incl. D&A
95,509.00
95,328.00
140,882.00
168,808.00
281,100.00
Gross Income
66,896.00
81,633.00
128,912.00
144,132.00
186,887.00
SG&A Expense
30,080.00
33,290.00
78,101.00
109,296.00
129,269.00
EBIT
36,220.00
48,343.00
50,811.00
34,836.00
57,618.00
Unusual Expense
3,882.00
-
148.00
465.00
1,667.00
Non Operating Income/Expense
85.00
1,569.00
774.00
1,576.00
1,628.00
Interest Expense
307.00
438.00
3,740.00
5,550.00
5,269.00
Pretax Income
40,175.00
46,501.00
47,829.00
31,479.00
51,772.00
Income Tax
7,900.00
11,226.00
11,438.00
4,653.00
9,309.00
Consolidated Net Income
32,275.00
35,275.00
36,391.00
26,826.00
42,463.00
Net Income
32,275.00
35,275.00
36,391.00
26,826.00
42,463.00
Net Income After Extraordinaries
32,275.00
35,275.00
36,391.00
26,826.00
42,463.00
Net Income Available to Common
32,275.00
35,275.00
36,391.00
26,826.00
42,463.00
EPS (Basic)
0.07
0.08
0.08
0.04
0.07
Basic Shares Outstanding
436,964.50
436,964.50
470,547.50
650,902.70
650,905.00
EPS (Diluted)
0.07
0.08
0.08
0.04
0.07
Diluted Shares Outstanding
436,964.50
436,964.50
470,547.50
650,902.70
650,905.00
EBITDA
44,005.00
56,611.00
72,343.00
57,336.00
81,738.00
Other Operating Expense
596.00
-
-
-
-
Non-Operating Interest Income
295.00
165.00
1,384.00
4,234.00
2,718.00

About CCM Duopharma Biotech Bhd

View Profile
Address
Lot 2599, Jalan Seruling 59
Klang Selangor 41200
Malaysia
Employees -
Website http://www.duopharma.com.my
Updated 09/14/2018
CCM Duopharma Biotech Bhd. is an investment holding company, which engages in the research, development, and commercialization of chemical and pharmaceutical products. Its products include analgesic, haemodialysis liquid, eye drops, antibiotic powder and dental cartridges.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.